Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The impressive clinical activity of small-molecule receptor tyrosine kinase inhibitors for oncogene-addicted subgroups of non-small-cell lung cancer (for example, those driven by activating mutations in the gene encoding epidermal growth factor receptor (EGFR) or rearrangements in the genes encoding the receptor tyrosine kinases anaplastic lymphoma...
Alternative Titles
Full title
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7043073
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7043073
Other Identifiers
ISSN
1474-175X,1474-1768
E-ISSN
1474-1768
DOI
10.1038/s41568-019-0179-8
